Very Frustrating, I have bought a few more
and Down She Goes!
Can't believe how many shareholders holding for past 5 years
are content with a non-existent ir dept.
One sentence on monster revenue producer Vyvase and we are okay with that?
we are a growth stock but say nothing about revenue dynamics for 2025-2026
we have a ceo implying 50 cents is great, yet we know our goal for years
is nasdaq and taking out the dollar?
we are profitable on the otc market, who knows this?
am I having buyers remorse, and only been here two months?
snup
Market Data 
Markets 
AI
